PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
24-Mar-2020 Cataract Devices market is flourishing around the globe though the key market players such as Abbott, Bausch & Lomb, Novartis, STAAR Surgical Company, Carl Zeiss AG, and Topcon Corporation among others Ricerca Alfa
24-Mar-2020 Global Cardiac Mapping Market| Focusing on Top Market Players including EP Solutions Sa, Abbott Laboratories, Koninklijke Philips N.V., Medtronic Plc, Microport Scientific Corporation, and Boston Scientific Corporation among others Ricerca Alfa
24-Mar-2020 Okayama University Research: Novel Blood-based Markers to Detect Alzheimer's Disease Okayama University
24-Mar-2020 AIKido Pharma Inc. Adopts Plan to Preserve Valuable Tax Assets AIkido Pharma Inc.
23-Mar-2020 Milestone Pharmaceuticals Announces Topline Results from First-of-its-kind Phase 3 NODE-301 Trial of Etripamil for At-home Acute PSVT Treatment Milestone Pharmaceuticals, Inc.
23-Mar-2020 Synairgen to start trial of SNG001 in COVID-19 imminently Synairgen plc
23-Mar-2020 Helsinn announces European approval of the IV formulation of AKYNZEO® (fosnetupitant / palonosetron) Helsinn Group
23-Mar-2020 Syncona Limited Business Update Syncona Limited
23-Mar-2020 All patients in the European MOB-015 Phase 3 study have completed their last visit Moberg Pharma AB
23-Mar-2020 Bone Therapeutics receives Clinical Trial Application (CTA) approval for next clinical studies of its two lead candidates BONE THERAPEUTICS
23-Mar-2020 Vaccitech and Oxford University Announce Promising Phase 2a Data on Prostate Cancer Immunotherapy Vaccitech
23-Mar-2020 Vaccitech and Oxford University Announce Promising Phase 2a Data on Prostate Cancer Immunotherapy Vaccitech Limited
23-Mar-2020 Immutep’s partner, EOC Pharma, reports completion of recruitment of phase I study of Efti Immutep
23-Mar-2020 INVESTIGATION REVEALS £21 MILLION NHS BILL FOR AVOIDABLE DEFICIENCIES IN HEART FAILURE BMJ journal
23-Mar-2020 ISA Pharma publishes phase 2 study data in major peer-reviewed journal ISA Pharmaceuticals
23-Mar-2020 NDA Group tackles increased regulatory complexity for Medical Device manufacturers through new division NDA Group
23-Mar-2020 Ergomed Announces Provision of Clinical Research Services for COVID-19 Clinical Study Ergomed plc
23-Mar-2020 Britain’s fastest-growing privately-owned pharma companies revealed Alantra
23-Mar-2020 Eureka Therapeutics Completes $45 Million Series E Financing and Enters into Strategic Collaboration with Lyell Immunopharma Eureka Therapeutics
23-Mar-2020 Abeona Therapeutics Announces First Patient Treated in Pivotal Phase III Clinical Trial Evaluating EB-101 Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa eona Therapeutics